DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Friday, 30 September 2016

Dr. Rajappa Vaidyanathan

Dr. Rajappa Vaidyanathan

Group Director-Chemical, Synthetic and Analytical Development at Bristol-Myers Squibb

Director and Head-Process Research and Development, Bristol-Myers Squibb, India

https://in.linkedin.com/in/rajappa-vaidyanathan-b6a4283
rajappa.vaidyanathan@bms.com

Scott Rychnovsky

srychnov@uci.edu

Professor

(949) 824-8292

1139 Natural Sciences II,3038B Frederick Reines Hall

Website:

Group Website

Position:

Faculty

Faculty Profile

Research Interests

Experience

Group Director-Chemical, Synthetic and Analytical Development

Bristol-Myers Squibb

April 2016 – Present (7 months)

Director-Early Phase Chemical Development

Bristol-Myers Squibb

November 2013 – March 2016 (2 years 5 months)Bangalore, India

Head-Process Research and Development

Bristol-Myers Squibb

April 2012 – October 2013 (1 year 7 months)Bangalore

Associate Research Fellow

Pfizer

November 2000 – April 2012 (11 years 6 months)

Education

University of California, Irvine

Ph.D., Chemistry

1995 – 1998

University of Minnesota-Twin Cities

Chemistry

1993 – 1995

Indian Institute of Technology, Madras

Master of Science (M.Sc.), Chemistry

1991 – 1993

Development of Safe, Robust, Environmentally Responsible Processes for New Chemical Entities
- Dr. V. Rajappa, Director & Head-Process R&D, Bristol-Myers Squibb, India

A PRESENTATION

Image result for scroll up arrow

Scroll with mouse to view 76 pages

13.11.2015: An extension lecture by Dr.Rajappa Vaidyanathan; organized by department of Chemical Engineering & Chemistry.

Image result for Biocon BMS Research Centre,

Image result for Biocon BMS Research Centre,

KIRAN SHAW, OWNER, BIOCON

/////////

Thursday, 29 September 2016

Bhaskar Reddy Guntoori, Ph.D.

Bhaskar Reddy Guntoori, Ph.D.
Senior Vice President, Process Chemistry

Dr. Bhaskar R. Guntoori joined Pharmaron as a Vice President of Process Chemistry in July 2011, and promoted to Senior Vice Presidnet in January 2016.
Prior to this appointment, Dr. Guntoori was a Senior Manager, R&D at ApotexPharmachem, Brantford, Canada.
He started at ApotexPharmachem in 1995 as a Chemist, held several positions within the Process R&D group before being promoted to Senior Manager R&D in 2004.

He was one of the principal contributors to the growth of the R&D team from less than ten members in 1995 to a group of eighty scientists. He oversaw the successful completion of more than forty API projects, from lab scale process development to scale-up and commercialization and contributed significantly to the growth of intellectual property of the company.

Dr. Guntoori received his Ph.D. in organic chemistry in 1988 from the University of Poona, India. Subsequently, he joined Sagami Chemical Research Centre, Japan to pursue industrial position under the advisory of Prof. T. Hiyama (1988-1990).
He then joined Prof. Steve Hanessian’s group at the University of Montreal (1990-1994).
Dr. Guntoori’s expertise covers broad area of synthetic chemistry, such as medicinal chemistry, total synthesis, methodologies and Process R&D. His research work is published in 14 peer-reviewed scientific journals and he is a co-inventor/co-author of more than 88 internationally issued patents/patent applications.

About Pharmaron
Pharmaron is a private, premier R&D service provider for the life science industry. Founded in 2003, Pharmaron has invested in its people and facilities, and established a broad spectrum of drug R&D service capabilities, ranging from synthetic and medicinal chemistry, biology, DMPK, pharmacology, safety assessment, radiochemistry and radiolabelled metabolism to chemical & pharmaceutical development. With about 4,000 employees and operations in China, the U.S. and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. For more information, please visit: www.pharmaron.com

///////

Tuesday, 27 September 2016

SUNITHA VYALA

Senior Scientist at Dr. Reddy's Laboratories

links

https://www.researchgate.net/profile/Sunitha_Vyala2

https://in.linkedin.com/in/sunitha-vyala-70657714/en

Experience

Senior Scientist

Dr. Reddy's Laboratories

January 2009 – Present (7 years 9 months)BACHUPALLY, HYDERABAD

SCREENING AND DEVELOPMENT OF POLYMORPHS DURING THE PRODUCT DEVELOPMENT OF ACTIVE PHARMACEUTICAL INGREDIENTS
Literature search, Product Development of the Active Pharmaceutical Ingredients includes gram scale development of APIs to Kilogram scale applying the QbD principles and DoE applications.
Usage of PAT tools to understand and monitor the reactions. Development of the product by the usage of eco-friendly solvents and cheaply available chemicals.

postdoctorant

CNRS

September 2008 – August 2009 (1 year)Rennes

Ionic liquids, Task Specific Onium salts, Continuous micro reactors and biocatalysis

Scientist

SAI Life Sciences Ltd

February 2008 – July 2008 (6 months)Shamirpet, Hyderabad

Synthesis of biologically active compounds

Education

Nalsar University of Law

Post-Graduate Diploma in Patents Law

2016

Patents Law

Indian institute of chemical technology

Doctor of Philosophy (PhD), Sythetic organic chemistry

2002 – 2008

Development of novel synthetic methodologies and its application towards the total synthesis of Scytophycin-C

University of Hyderabad

Post Graduate Diploma in Environmental Management, Environmental Science

2000 – 2001

Research experience

Oct 2009–
Dec 2014

SCIENTIST

Dr. Reddy's Laboratories · Research & Development

India · Hyderabad
Sep 2008–
Aug 2009

Post doctorant

French National Centre for Scientific Research · Michel Vaultier

France · Rennes, Brittany

Ionic liquids and Task specific onium salts
Feb 2008–
Jul 2008

Senior research associate

SAI Life Sciences Ltd · Research and development

India · Shamirpet

Synthesis of biologically active molecules
Mar 2002–
Dec 2007

Research fellow

Indian Institute of Chemical Technology · Natural Products Chemistry Group (IICT) · Dr. J.S Yadav group

India · Hyderabad

Processes for the preparation of agomelatine and its intermediates

EP 2562151 A1

Publication number	EP2562151 A1
Publication type	Application
Application number	EP20120181650
Publication date	27 Feb 2013
Filing date	24 Aug 2012
Priority date	25 Aug 2011
Inventors	Praveen Cherukupally, Sunitha Vyala, Satish Kumar Vujjini, Venkata Krishna Rao Badarla,Sreenadha Charyulu Kandala, Venkata Rama Krishnam Raju Datla, Venu Nalivela, Less «
Applicant	Dr. Reddy's Laboratories Ltd.
Export Citation	BiBTeX, EndNote, RefMan
Patent Citations (13), Non-Patent Citations (2), Referenced by (3),Classifications (16), Legal Events (6)

External Links: Espacenet, EP Register

ABSTRACT

Aspects of the present application relate to processes for the preparation of agomelatine and its intermediates which are used in manufacturing process of agomelatine.

July-August 2012, Volume 2, No.4

July-August 2012, Volume 2, No.4
Chemistry & Biology Interface, 2012, 2, 4, 206-257
(ISSN: 2249 – 4820)

An alternative route for the synthesis of N-substituted iminosugar derivative, miglitol
Ganta Madhusudhan Reddy, V.V.N.K.V. Prasada Raju, Kisara Satyanarayana, Vedantham Ravindra, Sunitha Vyala, G.Venkateshwarlu